C10ORF119 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.993800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.927400E-01
Normal-vs-Stage2
5.738000E-01
Normal-vs-Stage3
8.104200E-01
Normal-vs-Stage4
2.907400E-01
Stage1-vs-Stage2
6.645000E-01
Stage1-vs-Stage3
6.290400E-01
Stage1-vs-Stage4
2.487400E-01
Stage2-vs-Stage3
3.672800E-01
Stage2-vs-Stage4
1.492020E-01
Stage3-vs-Stage4
2.111800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.294800E-01
Normal-vs-AfricanAmerican
2.377400E-01
Normal-vs-Asian
8.394000E-01
Caucasian-vs-AfricanAmerican
4.234000E-01
Caucasian-vs-Asian
6.010200E-01
AfricanAmerican-vs-Asian
2.883000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.610000E-01
Normal-vs-Female
5.281800E-01
Male-vs-Female
5.993800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.163200E-01
Normal-vs-Age(41-60Yrs)
3.175200E-01
Normal-vs-Age(61-80Yrs)
7.409800E-01
Normal-vs-Age(81-100Yrs)
7.252200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.570550E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.532800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.277200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.774300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.644780E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.840400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.207800E-01
Normal-vs-Daily Drinker
8.291200E-01
Normal-vs-Weekly Drinker
6.732200E-01
Normal-vs-Occasional Drinker
4.149000E-01
Normal-vs-Social Drinker
6.261000E-01
Non Drinker-vs-Daily Drinker
8.985400E-01
Non Drinker-vs-Weekly Drinker
6.814400E-01
Non Drinker-vs-Occasional Drinker
1.779150E-01
Non Drinker-vs-Social Drinker
5.106200E-01
Daily Drinker-vs-Weekly Drinker
8.282800E-01
Daily Drinker-vs-Occasional Drinker
3.406000E-01
Daily Drinker-vs-Social Drinker
6.768800E-01
Weekly Drinker-vs-Occasional Drinker
4.569600E-01
Weekly Drinker-vs-Social Drinker
8.324200E-01
Occasional Drinker-vs-Social Drinker
6.204800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.715800E-01
Normal-vs-Grade 2
5.629200E-01
Normal-vs-Grade 3
8.958300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.959100E-03
Grade 1-vs-Grade 3
1.424500E-02
Grade 1-vs-Grade 4
3.715800E-01
Grade 2-vs-Grade 3
6.735400E-01
Grade 2-vs-Grade 4
5.629200E-01
Grade 3-vs-Grade 4
8.958300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.519600E-01
Normal-vs-NonDiabetic
6.694800E-01
Diabetic-vs-NonDiabetic
8.761600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.860800E-01
Normal-vs-NoPancreatitis
6.781400E-01
Pancreatitis-vs-NoPancreatitis
7.371800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.792800E-01
Normal-vs-N1
5.729400E-01
N0-vs-N1
8.637800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.095800E-01
Normal-vs-TP53-NonMutant
7.543600E-01
TP53-Mutant-vs-TP53-NonMutant
2.084000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
